email   Email Us: phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

ISSN: 2638-5910

Archives of Diabetes & Obesity

Research Article(ISSN: 2638-5910)

Differences in participant classification and intervention effects based on HbA1C and fasting plasma glucose among a community sample of African Americans

Volume 1 - Issue 5

Lovoria B Williams1*, Jeannette O Andrews2, Stephen W Looney3, Andrea M. Kriska4 and Janie Heath5

  • Author Information Open or Close
    • 1Augusta University, College of Nursing
    • 2South Carolina, College of Nursing, United States of America
    • 3Augusta University, Department of Population Health Sciences, United States of America
    • 4University of Pittsburgh, Department of Epidemiology, United States of America
    • 5University of Kentucky, College of Nursing, United States of America

    *Corresponding author: Lovoria B Williams, College of Nursing, United States of America

Received: November 16, 2018;   Published: November 26, 2018

DOI: 10.32474/ADO.2018.01.000122

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF


Since 2010, the American Diabetes Association has endorsed both HbA1C (A1C) and fasting plasma glucose (FPG) to determine diabetes risk. Given the discordance between classifications based on FPG and A1C and higher A1C levels among African Americans (AAs) than whites, we sought to examine the prevalence of normoglycemia, prediabetes, and diabetes among a community sample of adult AAs (n=704) screened for enrollment in a randomized Diabetes Prevention Program (DPP). We conducted a retrospective analysis to estimate the degree of discordance between risk categories based on FPG and A1C and examine the risk factors that predicted A1C and FPG levels. To determine differential effects on risk categories defined using FPG and A1C, we examined the effects of the program on the measures at 12 weeks post-intervention among the intervention arm participants.

The tests revealed different prevalence levels at baseline: A1C, 36.2% normoglycemia, 52% prediabetes and 11.8% diabetes; FPG, 81.1%, 16.8%, and 2%, respectively. There was discordance among A1C and FPG and among the risk categories (p<0.001). Both final regression models included age and waist circumference as predictors. For FPG, additional predictors were family history of diabetes and male gender. Post intervention, only those classified in the prediabetes category defined in terms of either test demonstrated intervention effects. Screening test choice results in different sample composition; both A1C and FPG respond to intervention effects among individuals classified in the prediabetes group only. These results have implications for research and clinical practice.

Keywords: HbA1C; Fasting plasma glucose; Community based; Screening; African Americans; Prediabetes

Abbreviations: DPP: Diabetes Prevention Program; FPG: fasting plasma glucose; ADA: American Diabetes Association; ARIC: Atherosclerosis Risk in Communities

Abstract| Introduction| Materials and Methods| Statistics| Results| Discussion| Conclusion| Acknowledgement| References|